Nathan Peiffer‐Smadja
Université Claude Bernard Lyon 1(FR)Délégation Paris 5(FR)Inserm(FR)Délégation Paris 7(FR)Université Paris Cité(FR)National Institute for Health Research(GB)Sorbonne Université(FR)Université Sorbonne Paris Nord(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Centre d'Immunologie et des Maladies Infectieuses(FR)Hôpital Bichat-Claude-Bernard(FR)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Antibiotic Use and Resistance, COVID-19 and healthcare impacts
Most-Cited Works
- → Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review(2021)942 cited
- → Type 1 interferons as a potential treatment against COVID-19(2020)550 cited
- → Machine learning for clinical decision support in infectious diseases: a narrative review of current applications(2019)519 cited
- → Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial(2021)340 cited
- → Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis(2020)311 cited
- → Open science saves lives: lessons from the COVID-19 pandemic(2021)